最好免费观看高清在线,中文字幕在线日亚洲9,亚洲情+欧美,亚洲欧美丝袜精品久久,亚洲国产另类久久久精品黑人

產(chǎn)品資料
產(chǎn)品[

CRL-2265 CEM/C1 人急性**細胞白血病細胞

]資料
如果您對該產(chǎn)品感興趣的話,可以 sendmsg
產(chǎn)品名稱: CRL-2265 CEM/C1 人急性**細胞白血病細胞
產(chǎn)品型號: CRL-2265
產(chǎn)品廠商: 美國標準生物品收藏中心（ATCC）
產(chǎn)品文檔: 無相關文檔


簡單介紹

CRL-2265 CEM/C1 人急性**細胞白血病細胞， ATCC 細胞|細胞系|細胞株|腫瘤細胞|細胞；細胞庫管理規(guī)范，提供的細胞株背景清楚，提供參考文獻和培養(yǎng)條件！


CRL-2265 CEM/C1 人急性**細胞白血病細胞 的詳細介紹
CRL-2265 CEM/C1 人急性**細胞白血病細胞
ATCC® Number: CRL-2265? Price:  
Designations: CEM/C1
Depositors: WG Harker
Biosafety Level: 1
Shipped: frozen
Medium & Serum: See Propagation
Growth Properties: suspension
Organism: Homo sapiens
Morphology: lymphoblast
Source: Organ: peripheral blood
Disease: acute lymphoblastic leukemia
Cell Type: T lymphoblast;
Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Age: 4 years
Gender: female
Ethnicity: Caucasian
Comments: CEM/C1 is a camptothecin (CPT) resistant derivative of the human T cell leukemia cell line CCRF-CEM (see ATCC CCL-119).
The cell line was selected and subcloned in 1991 for resistance to CPT.
The cells exhibit cross resistance to both the water soluble (topotecan) and water insoluble (9-amino-CPT and 10,11-methylenedioxy-CPT) analogs of CPT.
CEM/C1 cells are approximately 31 fold less sensitive to CPT than the parental CEM cells.
CEM/C1 cells display atypical multidrug resistance (MDR) and altered topoisomerase I catalytic activity.
Resistance to CPT is stable for up to six months.
Propagation: ATCC complete growth medium: The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, Catalog No. 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
Temperature: 37.0°C
Subculturing: Medium Renewal: Every 2 to 3 days
Cultures can be maintained by addition or replacement of medium. Establish new cultures at 2 X 10 exp5 viable cells/ml and maintain between 1 X 10 exp5 and 2 X 10 exp6.
Preservation: culture medium 95%; DMSO, 5%
Doubling Time: 26 hrs
Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001
recommended serum:ATCC 30-2020
parental cell line:ATCC CCL-119
References: 22339: Kapoor R, et al. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin. Oncol. Res. 7: 83-95, 1995. PubMed: 7579731
23117: Fujimori A, et al. Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin. Cancer Res. 55: 1339-1346, 1995. PubMed: 7882333
產(chǎn)品留言
標題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗證碼
點擊換一張
注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請您留下您的詳細聯(lián)系方式!

聯(lián)系我們
產(chǎn)品搜索

細胞系，ATCC細胞，ATCC菌種，細胞系目錄，ATCC，鼠傷寒沙門氏菌，atcc細胞庫，人**瘤細胞，人食管癌細胞，ATCC 19404，ATCC 25922，ATCC 19146，微生物菌種，細胞株，標準菌株，ATCC中國，atcc上海代理，CMCC 菌株，ATCC菌株，細胞目錄，質控菌株，腫瘤細胞株，乳腺癌細胞系，人肝癌細胞系
產(chǎn)品目錄

Copyright? 2003-2025  上海復祥生物科技有限公司版權所有            電話：021-35080510
傳真：021-35080520    地址：上海市虹口區(qū)赤峰路630號南雁大廈1901室    郵編： 滬ICP備10013034號-3  

  

滬公網(wǎng)安備 31010902002429號